GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497) » Definitions » Capital Expenditure

Jiangxi Fushine Pharmaceutical Co (SZSE:300497) Capital Expenditure : ¥-227.99 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Jiangxi Fushine Pharmaceutical Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Jiangxi Fushine Pharmaceutical Co's cash flow for capital expenditures for the three months ended in Mar. 2025 was ¥-128 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-227.99 Mil.

Jiangxi Fushine Pharmaceutical Co Capital Expenditure Historical Data

The historical data trend for Jiangxi Fushine Pharmaceutical Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangxi Fushine Pharmaceutical Co Capital Expenditure Chart

Jiangxi Fushine Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -449.24 -679.60 -459.41 -242.23 -141.75

Jiangxi Fushine Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -41.38 -45.91 -39.74 -14.72 -127.62

Jiangxi Fushine Pharmaceutical Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-227.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangxi Fushine Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497) » Definitions » Capital Expenditure
Comparable Companies
BJSE:839273 SHSE:688046 SZSE:300871 SHSE:603566 BJSE:833575 SHSE:603590 SHSE:688075 SHSE:688488 SZSE:300318 SHSE:688293 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No.2 YULI Industrial Zone, Changjiang district, Jiangxi Province, Jingdezhen, CHN, 333000
Website
http://www.fushine.cn
Jiangxi Fushine Pharmaceutical Co Ltd is engaged in research and development, manufactures and sells APIs and pharmaceutical intermediates. It offers penicillin, carbapenem, and other products.
Executives
Liu Ying Executives
Peng Yun Secretary Dong
Zhang Xiang Ming Executives
Wei Hai Peng Executives
Bao Jian Hua Directors, executives
Li Hui Yue Director
Dai Zhen Liang Executives
Yang Guang Executives
Chen Ying Hui Executives
Ke Dan Director
Xu Chun Xia Directors, executives
Yu Wen Jun Director
Cheng Rong Wu Directors, executives
Liu Zhi Min Executives
Tang De Ping Executives

Jiangxi Fushine Pharmaceutical Co Headlines

No Headlines